Redemption - R&D
Payments companies reported to CMS as associated with Redemption - R&D. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Redemption - R&D, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Redemption - R&D
These are the largest totals companies reported as associated with Redemption - R&D. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Aaron Mates | Parker, CO | Orthopaedic Surgery | $12,544.02 |
| Eric Naasz | Fullerton, CA | Foot & Ankle Surgery | $12,504.61 |
| Jeffrey Loveland | Sparta, TN | Podiatrist | $12,251.68 |
| Scott Maling | Mesa, AZ | Foot & Ankle Surgery | $12,117.73 |
| Mario Cala | Hialeah, FL | Foot & Ankle Surgery | $10,742.40 |
| Lee Hlad | Gahanna, OH | Foot & Ankle Surgery | $4,711.74 |
| Peter Blume | New Haven, CT | Podiatrist | $763.32 |
| Daniel Pierini | Southlake, TX | Podiatrist | $232.35 |
| Devin Bland | Phoenix, AZ | Foot & Ankle Surgery | $46.43 |
Prescribed Redemption - R&D?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.